Pharmacotherapy in Mental Retardation and Autism

REFERENCES

• Abramowitz, A. J., Eckstrand, D., O'Leary, S. G., & Dulcan, M. K. (1992). ADHD children's response to stimulant medication and two intensities of a behavioral intervention. Behavior Modification, 16, 193–203.
   PubMed Web of Science ®Google Scholar
• Achenbach, T. M. (1986). Child behavior checklist direct observation form. Burlington, VT: Center for Children, Youth, and Families, University of Vermont.
   Google Scholar
• Aman, M. G. (1983). Psychoactive drugs in mental retardation. In J. L. Matson & F. Andrasik (Eds.), Treatment issues and innovations in mental retardation (pp. 455–513). New York: Plenum Press.
   Google Scholar
• Aman, M. G. (1984). Drugs and learning in mentally retarded persons. In G. D. Burrows & J. S. Werry (Eds.), Advances in human psychopharmacology (vol. 3; pp. 121–163). Greenwich, CT: JAI Press.
   Google Scholar
• Aman, M. G. (1991a). Pharmacotherapy in the developmental disabilities: New developments. Australia and New Zealand Journal of Developmental Disabilities, 17, 183–199.
   Google Scholar
• Aman, M. G. (1991 b). Assessing psychopathology and behavior problems in persons with mental retardation: A review of available instruments. Rockville, MD: U.S. Department of Health and Human Services.
   Google Scholar
• Aman, M. G., Field, C. J., & Bridgman, G. D. (1985). City-wide survey of drug patterns among non-institutionalized retarded persons. Applied Research in Mental Retardation, 5, 159–171.
   Google Scholar
• Aman, M. G., & Kern, R. A. (1989). Review of fenfluramine in the treatment of the developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 549–565.
   PubMed Web of Science ®Google Scholar
• Aman, M. G., Kern, R. A., McGhee, D. E., & Arnold, L. E. (1992). Fenfluramine and methylphenidate in children with mental retardation and ADHD: Laboratory effects. Manuscript submitted for publication, Ohio State University.
   Google Scholar
• Aman, M. G., Kern, R. A., McGhee, D. E., & Arnold, L. E. (in press). Fenfluramine and methylphenidate in children with mental retardation and ADHD: Clinical and side effects. Journal of the American Academy of Child and Adolescent Psychiatry.
   Google Scholar
• Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991a). The clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 246–256.
   PubMed Web of Science ®Google Scholar
• Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991b). Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 816–824.
   PubMed Web of Science ®Google Scholar
• Aman, M. G., Paxton, J. W., Field, C. J., & Foote, S. E. (1986). Survey of drug concentrations in retarded patients receiving anticonvulsant medication. American Journal of Mental Deficiency, 84, 331–338.
   Google Scholar
• Aman, M. G., & Singh, N. N. (1980). The usefulness of thioridazine for treating childhood disorders. Fact or folklore? American Journal of Mental Deficiency, 84, 331–338.
   PubMedGoogle Scholar
• Aman, M. G., & Singh, N. N. (1985). Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment. Journal of Mental Deficiency Research, 29, 187–195.
   PubMedGoogle Scholar
• Aman, M. G., & Singh, N. N. (1991). Pharmacological intervention. In J. L. Matson & J. H. Mulick (Eds.), Handbook of Mental Retardation (2nd ed.; pp. 347–372). New York: Pergamon Press.
   Google Scholar
• Aman, M. G., Teehan, C. J., White, A. J., Turbott, S. H., & Vaithianathan, C. (1989). Haloperidol treatment with chronically medicated residents: Dose effects on clinical behavior and reinforcement contingencies. American Journal of Mental Retardation, 93, 452–460.
   PubMedGoogle Scholar
• Aman, M. G., & White, A. J. (1988). Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. Journal of Autism and Developmental Disorders, 18, 355–366.
   PubMed Web of Science ®Google Scholar
• Aman, M. G., White, A. J., & Field, C. J. (1984). Chlorpromazine effects on stereotypic and conditioned behavior — A pilot study. Journal of Mental Deficiency Research, 28, 253–260.
   PubMedGoogle Scholar
• Aman, M. G., White, A. J., Vaithianathan, D., & Teehan, C. J. (1986). Preliminary study of Imipramine in profoundly retarded residents. Journal of Autism and Developmental Disorders, 16, 263–273.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
   Google Scholar
• Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.
   PubMed Web of Science ®Google Scholar
• Ando, H., & Yoshimura, I. (1978). Prevalence of maladaptive behavior in retarded children as a function of IQ and age. Journal of Abnormal Child Psychology, 6, 345–349.
   PubMed Web of Science ®Google Scholar
• Ayd, F., Jr. (1983). Depot pipotiazine: Thirteen years later. International Drug Therapy Newsletter, 18, 5–8.
   Google Scholar
• Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford.
   Google Scholar
• Barkley, R. A., & Cunningham, C. E. (1978). Do stimulant drugs improve the academic performance of hyperkinetic children? Clinical Pediatrics, 17, 85–92.
   PubMed Web of Science ®Google Scholar
• Barlow, D. H. (1984). Single case experimental designs: Strategies for studying behavior change (2nd ed.). New York: Pergamon Press.
   Google Scholar
• Bass, J. N., & Beltis, J. (1991). Therapeutic effect of fluoxetine on naltrexone-resistant self-injurious behavior in an adolescent with mental retardation. Journal of Child and Adolescent Psychopharmacology, 1, 331–340.
   PubMedGoogle Scholar
• Behar, L. B., & Stringfield, S. A. (1974). Manual for the Preschool Behavior Questionnaire. Durham, NC: Learning Institute of North Carolina.
   Google Scholar
• Biederman, J., Baldessarini, R. J., Wright, V., Knee, D., & Harmatz, J. S. (1989). Journal of the American Academy of Child and Adolescent Psychiatry, 28, 777–784.
   PubMed Web of Science ®Google Scholar
• Birmaher, B., Quintana, H., & Greenhill, L. L. (1988). Methylphenidate treatment of hyperactive autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27(2), 248–251.
   PubMed Web of Science ®Google Scholar
• Blackwell, B., & Currah, J. (1973). The psychopharmacology of nocturnal enuresis. In I. Kolvin, R. McKeith, & S. Meadow (Eds.), Bladder control and enuresis (pp. 231–257). London: Heineman.
   Google Scholar
• Borison, R. (1985, May). The recognition and management of drug-induced movement disorders (reversible type). Presented at the annual meeting of the American Psychiatric Association, Dallas, TX. (Available from author, Department of Psychiatry, Medical College of Georgia, Augusta, GA).
   Google Scholar
• Buschke, H., & Fuld, P. A. (1974). Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology, 24, 1019–1025.
   PubMed Web of Science ®Google Scholar
• Cade, J. F. J. (1949). Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia, 36, 349–352.
   Web of Science ®Google Scholar
• Campbell, M. (1975). Pharmacotherapy in early infantile autism. Biological Psychiatry, 10, 399–423.
   PubMed Web of Science ®Google Scholar
• Campbell, M., Adams, P., Small, A. M., McVeigh, L., & Curren, E. L. (1988). Naltrexone in infantile autism. Psychopharmamlogy Bulletin, 24, 135–139.
   PubMedGoogle Scholar
• Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C., & Sachar, E. J. (1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 17, 640–655.
   PubMedGoogle Scholar
• Campbell, M., Overall, J. E., Small, A. M., Sokol, M. S., Spencer, E. K., Adams, P., Foltz, R. L., Monti, K. M., Perry, R., Nobler, M., & Roberts, E. (1989). Naltrexone in autistic children: An acute open dose range tolerance trial. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 200–206.
   PubMed Web of Science ®Google Scholar
• Campbell, M., Small, A. M., Collins, P. J., Friedman, E., David, R., & Genieser, N. (1976). Levodopa and levoamphetamine: A crossover study in young schizophrenic children. Current Therapeutic Research, 19, 70–86.
   PubMed Web of Science ®Google Scholar
• Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 120, 650–656.
   Google Scholar
• Chandler, M., Gualtieri, C. T., & Fahs, J. J. (1988). Other psychotropic drugs: Stimulants, antidepressants, the anxiolytics, and lithium carbonate. In M. G. Aman & N. N. Singh (Eds.), Psychopharmacology of developmental disabilities (pp. 119–145). New York: Springer-Verlag.
   Google Scholar
• Claghorn, J. L. (1972). A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children. Current Therapeutic Research, 14, 785–789.
   PubMed Web of Science ®Google Scholar
• Cohen, I. L., Campbell, M., Posner, D., Small, A. M., Trickel, D., & Anderson, L. T. (1980). Behavioral effects of haloperidol in young autistic children. Journal of the American Academy of Child Psychiatry, 19, 665–677.
   PubMedGoogle Scholar
• Comings, D. E., & Comings, B. G. (1987). A controlled study of Tourette syndrome. I. Attention deficit disorder, learning disorders, and school problems. American Journal of Human Genetics, 141, 701–741.
   Google Scholar
• Commission on classification and terminology of the international league against epilepsy: Proposal for the classification of epilepsies and epileptic syndromes. (1985). Epilepsia, 26, 268–278.
   PubMed Web of Science ®Google Scholar
• Cooper, A. F., & Rowlie, H. C. (1973). Control of gross self-mutilation with lithium carbonate. British Journal of Psychiatry, 122, 370–371.
   PubMed Web of Science ®Google Scholar
• Cramer, J. A., Smith, D. B., Mattison, R. H., Excueta, A. V. D., Collins, J. F., & the VA Cooperative Study Group. (1983). A method of quantification for the evaluation of antiepileptic drug therapy. Neurology, 33, (Suppl. 1), 26–27.
   PubMed Web of Science ®Google Scholar
• Cullinan, D., Gadow, K. D., & Epstein, M. H. (in press). Psychotropic drug treatment among learning disabled, educable mentally retarded, and seriously emotionally disturbed students. Journal of Abnormal Child Psychology.
   Google Scholar
• Dostal, T., & Zvolsky, P. (1970). Antiaggressive effects of lithium salts in severely mentally retarded adolescents. International Pharmacopsychiatry, 5, 203–207.
   Google Scholar
• Engelhardt, D. M. (1974). Withdrawal Emergent Symptoms (WES) Checklist. (Available from author on request. Department of Psychiatry, Downstate Medical Center, State University of New York, 460 Clarkson Ave., Brooklyn, NY 11203).
   Google Scholar
• Epstein, M. H., Cullinan, D., & Gadow, K. (1986). Teacher ratings of hyperactivity in learning-disabled, emotionally disturbed, and mentally retarded children. Journal of Special Education, 22, 219–229.
   Web of Science ®Google Scholar
• Evans, R. W., Clay, T. H., & Gualtieri, T. (1987). Carbamazepine in pediatric psychiatry. Journal of American Academy of Child and Adolescent Psychiatry, 26, 2–8.
   PubMed Web of Science ®Google Scholar
• Fankhauser, M. S., Karumanchi, V. C., German, M. L., Yates, A., & Karumanchi, S. D. (1992). A doubleblind, placebo-controlled study of the efficacy of transdermal Clonidine in autism. Journal of Clinical Psychiatry, 53, 77–82.
   PubMed Web of Science ®Google Scholar
• Feldman, H., Crumrine, P., Handen, B. L., Alvin, R., & Teodori, J. (1989). Methylphenidate in children with seizures and attention deficit disorder. American Journal of Diseases of Children, 143, 1081–1086.
   PubMedGoogle Scholar
• Field, C. J., Aman, M. G., White, A. J., & Vaithianathan, C. (1986). Single-subject study of Imipramine in a mentally retarded woman with depressive symptoms. Journal of Mental Deficiency Research, 30, 191–198.
   PubMedGoogle Scholar
• Gadow, K. D. (1975, October). Pills and preschool: Medication usage with young children in special education. Paper presented at the Illinois Council for Exceptional Children, Chicago, IL.
   Google Scholar
• Gadow, K. D. (1977). Psychotropic and antiepileptic drug treatment with children in early childhood special education. Champaign, IL: University of Illinois, Institute for Child Behavior and Development. (ERIC Document Reproduction Service Number ED 162 294)
   Google Scholar
• Gadow, K. D., & Kalachnik, J. (1981). Prevalence and pattern of drug treatment for behavior and seizure disorders of TMR students. American Journal of Mental Deficiency, 85, 588–595.
   PubMedGoogle Scholar
• Gadow, K. D., & Poling, A. G. (1988). Pharmacotherapy and mental retardation. Boston, MA: College Hill Press.
   Google Scholar
• Gay, P. E. (1984). Effects of antiepileptic drugs and seizure type on operant responding in mentally retarded persons. Epilepsia, 25, 377–386.
   PubMed Web of Science ®Google Scholar
• Geller, E., Ritvo, E. R., Freeman, B. J., & Yuwiler, A. (1982). Preliminary observations on the effects of fenfluramine on blood serotonin and symptoms in three autistic boys. New England Journal of Medicine, 307, 165–169.
   PubMed Web of Science ®Google Scholar
• Ghaziuddin, M., Tsai, L. Y., & Ghaziuddin, N. (1992, April). Use of clonidine in children with mental retardation: A pilot study. Paper presented at the American Academy of Child and Adolescent Psychiatry Conference. New Orleans, LA.
   Google Scholar
• Gofman, H. (1972–1973). Interval and final rating sheets on side-effects. Psychopharmacology Bulletin (Special Issue), 8–9, 182–187.
   Google Scholar
• Goldberg, J. B., & Kurland, A. A. (1970). Dilantin treatment of hospitalized cultural-familial retardation. Journal of Nervous and Mental Disease, 150, 133–137.
   PubMed Web of Science ®Google Scholar
• Golden, G. S., & Greenhill, L. (1981). Tourette syndrome in mentally retarded children. Mental Retardation, 19, 17–19.
   PubMedGoogle Scholar
• Goldstein, M., Anderson, L. T., Reuben, R., & Dancis, J. (1985). Self-mutilation in Lesch-Nyhan disease in caused by dopaminergic denervation. The Lancet, 1, 338–339.
   PubMed Web of Science ®Google Scholar
• Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978). Normative data on revised Conners parent and teacher rating scales. Journal of Abnormal Child Psychology, 6, 221–236.
   PubMed Web of Science ®Google Scholar
• Gualtieri, C. T., Golden, R. N., & Fahs, J. J. (1983). New developments in pediatric psychopharmacology. Journal of Developmental and Behavioral Pediatrics, 4, 202–209.
   PubMed Web of Science ®Google Scholar
• Gualtieri, C. T., & Hawk, B. (1982). Antidepressant and antimanic drugs. In S. I. Breuning & A. D. Poling (Eds.), Drugs and mental retardation (pp. 215–234). Springfield, IL: Thomas.
   Google Scholar
• Handen, B. L., Breaux, A. M., Gosling, A., Ploof, D. L., & Feldman, H. (1990). Efficacy of Ritalin among mentally retarded children with ADHD. Pediatrics, 86, 922–930.
   PubMed Web of Science ®Google Scholar
• Handen, B. L., Feldman, H., Gosling, A., Breaux, A. M., & McAuliffe, S. (1991). Adverse side effects of Ritalin among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 241–245.
   PubMed Web of Science ®Google Scholar
• Handen, B. L., Janosky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 455–461.
   PubMed Web of Science ®Google Scholar
• Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, I., Werner, A., & Zelnik, N. (1987). Naltrexone decreases self-injurious behavior. Annals of Neurology, 22, 550–552.
   PubMed Web of Science ®Google Scholar
• Hetrick, W., Taylor, D., Touchette, P., Lott, I., Barron, J., & Sandman, C. (1991, May). Treatment of self-injurious behavior with naltrexone: Effects on SIB, learning, and neurological function. Paper presented at the Gatlinburg Conference on Research and Theory in Mental Retardation and Developmental Disabilities. Key Biscayne, FL.
   Google Scholar
• Hill, B. K., Balow, E. A., & Bruininks, R. H. (1985). A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people. Psychopharmacology Bulletin, 21, 279–284.
   PubMed Web of Science ®Google Scholar
• Hill, B. K., Lakin, K. C., & Bruininks, R. H. (1984). Trends in residential services for mentally retarded people: 1977–1982. Journal of the Association for Persons urith Severe Handicaps, 9, 243–250.
   Google Scholar
• Hoza, B., Pelham, W. E., Sams, S. E., & Carlson, C. (1992). An examination of the “dosage” effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children. Behavior Modification, 16, 164–192.
   PubMed Web of Science ®Google Scholar
• Hunt, R. D., Capper, L., & O'Connell, P. (1990). Clonidine in child and adolescent psychiatry. Journal of Child and Adolescent Psychopharmacology, 1, 87–98.
   PubMedGoogle Scholar
• Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention-deficit disorder and hyperactivity: Report of a doubleblind placebo-controlled crossover study. Journal of American Academy of Child Psychiatry, 24, 617–629.
   PubMedGoogle Scholar
• Intagliata, J., & Rinck, C. (1985). Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacology Bulletin, 21, 268–278.
   PubMed Web of Science ®Google Scholar
• Jakab, I. (1984). Short-term effect of thioridazine tablets versus suspension on emotionally disturbed/retarded children. Journal of Clinical Psychopharmacology, 4, 210–215.
   PubMed Web of Science ®Google Scholar
• Jaselskis, C. A., Cook, E. H., Jr., Fletcher, K. E., & Leventhal, B. L. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. Journal of Clinical Psychopharmacology, 12, 322–327.
   PubMed Web of Science ®Google Scholar
• Kalachnik, J. E. (1985). Monitoring for side-effects system (MOSES). Unpublished manuscript.
   Google Scholar
• Kardash, S., Hillman, E. S, & Werry, J. (1968). Efficacy of imipramine in childhood enuresis: A doubleblind control study with placebo. Canadian Medical Association Journal, 99, 263–266.
   PubMed Web of Science ®Google Scholar
• Kars, H., Broekema, W., Glaudemans-van Gelderen, I., Verhoeven, W. M. A., & van Ree, J. M. (1990). Naltrexone attenuates self-injurious behavior in mentally retarded subjects. Biological Psychiatry, 27, 741–746.
   PubMed Web of Science ®Google Scholar
• Kaufman, K. R., & Katz-Garns, L. (1979). Epilepsy, mental retardation, and anticonvulsant therapy. American Journal of Mental Deficiency, 84, 256–259.
   PubMedGoogle Scholar
• King, B. H. (1991). Fluoxetine reduced self-injurious behavior in an adolescent with mental retardation. Journal of Child and Adolescent Psychopharmacology, 1, 321–329.
   PubMedGoogle Scholar
• LaVeck, G. D., & Buckley, P. (1961). The use of psychopharmacologic agents in retarded children with behavioral disorders. Journal of Chronic Diseases, 13, 174–183.
   PubMedGoogle Scholar
• Leekman, J. F., Anderson, G. M., Cohen, D. J., Ort, S., Harcherik, D. F., & Hoder, E. L. (1984). Whole blood serotonin and tryptophan levels in Tourette's syndrome: Effects of acute and chronic clonidine treatment. Life Science, 35, 2497–2503.
   PubMed Web of Science ®Google Scholar
• Le Vann, L. (1971). Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. American Journal of Mental Deficiency, 75, 719–723.
   PubMedGoogle Scholar
• Lipman, R. S., DiMascio, A., Reatig, N., & Kirson, T. (1978). Psychotropic drugs and mentally retarded children. In M. A. Lipton, A. DiMascio, & K. F. Killam (Eds.), Psychopharmacology: A generation of progress (pp. 1437–1449). New York: Raven Press.
   Google Scholar
• Lovaas, O. I. (1977). Language development through behavior modification. New York: Wiley.
   Google Scholar
• Lynch, D. M., Ehatamby, C. L. S., & Anderson, A. A. (1985). Pipothiazine palmitate in the management of aggressive mentally handicapped patients. British Journal of Psychiatry, 146, 525–529.
   Google Scholar
• Marholin, D., Touchette, P. E., & Stewart, R. M. (1979). Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12, 159–171.
   PubMed Web of Science ®Google Scholar
• Markowitz, P. I. (1990). Fluoxetine treatment of self-injurious behavior in mentally retarded patients. Journal of Clinical Psychopharmacology, 10, 299–300.
   PubMedGoogle Scholar
• Markowitz, P. I. (1992). Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study. Journal of Clinical Psychopharmacology, 12, 27–31.
   PubMed Web of Science ®Google Scholar
• Martin, J. E., & Agran, M. (1985). Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements. Applied Research in Mental Retardation, 6, 33–49.
   PubMedGoogle Scholar
• McNair, D. M. (1977). Antianxiety drugs and human performance. Archives of General Psychiatry, 29, 611–617.
   Google Scholar
• Moore, J. W. (1960). The effects of a tranquilizer (Thorazine) on the intelligence and achievement of educable mentally retarded women. Dissertation Abstracts, 20, 3200.
   Google Scholar
• Naylor, G. J., Donald, J. M., LePoidevin, D., Reid, A. H. (1974). A double-blind trial of long-term lithium therapy in mental defectives. British Journal of Psychiatry, 124, 52–57.
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health. (1985a). DOTES (Dosage Record and Treatment Emergent Symptom Scale). Psychopharmacology Bulletin, 20, 1067–1068.
   Google Scholar
• National Institute of Mental Health. (1985b). STRESS (Subjective Treatment Emergent Symptoms Scale). Psychopharmacology Bulletin, 20, 1073–1075.
   Google Scholar
• National Institute of Mental Health. (1986). Systematic Assessment for Treatment Emergent Events (SAFTEE). Psychopharmacology Bulletin, 22, 347–381.
   Google Scholar
• Panksepp, J., & Lensing, P. (1991). Brief report: A synopsis of an open-trial of naltrexone treatment of autism with four children. Journal of Autism and Developmental Disorders, 21, 243–249.
   PubMed Web of Science ®Google Scholar
• Pelham, W. E. (1986). The effects of stimulant drugs on learning and achievement in hyperactive and learning-disabled children. In J. K. Torgesen & B. Wong (Eds.), Psychological and educational perspectives on learning disabilities (pp. 259–295). New York: Academic Press.
   Google Scholar
• Pelham, W. E., Milich, R., Murphy, D. A., & Murphy, H. A. (1989). Normative data on the IOWA Conners teacher rating scale. Journal of Clinical Child Psychology, 18, 259–262.
   Google Scholar
• Physician's Desk Reference. (1993). Oradell, NJ: Medical Economics Co.
   Google Scholar
• Rapport, M. D., DuPaul, G. J., Stoner, G., & Jones, J. T. (1986). Comparing classroom and clinic measures of attention deficit disorder: Differential, idiosyncratic, and dose-response effects of methylphenidate. Journal of Consulting and Clinical Psychology, 54, 334–341.
   PubMed Web of Science ®Google Scholar
• Ratey, J. J., Morrill, R., & Oxenkrug, G. (1983). Use of propranolol for provoked and unprovoked episodes of rage. American Journal of Psychiatry, 140, 1356–1357.
   PubMed Web of Science ®Google Scholar
• Reid, A. H., Naylor, G. J., & Kay, D. S. G. (1981). A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychological Medicine, 11, 109–113.
   PubMed Web of Science ®Google Scholar
• Ricketts, R. W., Goza, A. B., Ellis, C. R., Singh, Y. N., Singh, N. N., & Cooke, J. C. (in press). Fluoxetine treatment of severe self-injury in young adults with mental retardation. Journal of the American Academy qf Child and Adolescent Psychiatry.
   Google Scholar
• Santilli, N., Dodson, W. E., & Walton, A. V. (1991). Students with seizures: A manual for school nurses. Cedar Grove, NJ: Health Scan Publications.
   Google Scholar
• Santilli, N., & Sierzant, T. (1987). Advances in the treatment of epilepsy. Journal of Neuroscience Nursing, 19, 141–157.
   PubMedGoogle Scholar
• Schain, R. J. (1979). Problems with the use of conventional anticonvulsant drugs in mentally retarded individuals. Brain and Development, 1, 77–82.
   PubMedGoogle Scholar
• Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315–320.
   PubMed Web of Science ®Google Scholar
• Schell, R. M., Pelham, W. E., Bender, M. E., Andree, J. A., Law, T., & Robbins, F. R. (1986). The concurrent assessment of behavioral and psychostimulant interventions: A controlled case study. Behavioral Assessment, 8, 373–384.
   Google Scholar
• Selikowitz, M., Sunman, J., Pendergast, A., & Wright, S. (1990). Fenfluramine in Prader-Willi syndrome: A double blind, placebo controlled trial. Archives of Disease in Childhood, 65, 112–114.
   PubMed Web of Science ®Google Scholar
• Simpson, G. M., & Angus, J. W. S. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavia (Suppl. 212), 11–19.
   Google Scholar
• Singh, N. N., & Aman, M. G. (1981). Effects of thioridazine dosage on the behavior of severely mentally retarded persons. American Journal of Mental Deficiency, 85, 580–587.
   PubMedGoogle Scholar
• Strayhorn, J. M., Rapp, N., Donina, W., & Strain, P. S. (1988). Randomized trial of methylphenidate for an autistic child. Journal of the American Academy of Child and Adolescent Psychiatry, 27(2), 244–247.
   PubMed Web of Science ®Google Scholar
• Swanson, J., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.
   PubMed Web of Science ®Google Scholar
• Trimble, M. R., & Corbett, J. A. (1980). Behavioural and cognitive disturbances in epileptic children. Irish Medical Journal, 73, 21–28.
   PubMedGoogle Scholar
• Ucer, E., & Kreger, C. (1969). A double-blind study comparing haloperidol with thioridazine in emotionally disturbed mentally retarded children. Current Therapeutic Research, 11, 278–283.
   PubMed Web of Science ®Google Scholar
• Walters, A., Singh, N. N., & Beale, I. L. (1977). Effects of lorazepam on hyperactivity in retarded children. New Zealand Medical Journal, 86, 473–475.
   PubMed Web of Science ®Google Scholar
• Werry, J. (1980). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27–35.
   PubMed Web of Science ®Google Scholar
• White, T. J., & Aman, M. G. (1985). Pimozide treatment in disruptive severely retarded patients. Australian and New Zealand Journal of Psychiatry, 19, 92–94.
   PubMed Web of Science ®Google Scholar
• Williams, D. T., Mehl, R., Yudofsky, S., Adams, D., & Roseman, B. (1982). The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of the American Academy of Child Psychiatry, 21, 129–135.
   PubMedGoogle Scholar
• Wolf, S. M., & Forsythe, A. (1978). Behavior disturbances, phenobarbital, and febrile seizures. Pediatrics, 61, 728–731.
   PubMed Web of Science ®Google Scholar